Details for New Drug Application (NDA): 217329
✉ Email this page to a colleague
NDA 217329 describes FOSTAMATINIB DISODIUM, which is a drug marketed by Annora Pharma and is included in one NDA. Additional details are available on the FOSTAMATINIB DISODIUM profile page.
The generic ingredient in FOSTAMATINIB DISODIUM is fostamatinib disodium. One supplier is listed for this compound. Additional details are available on the fostamatinib disodium profile page.
The generic ingredient in FOSTAMATINIB DISODIUM is fostamatinib disodium. One supplier is listed for this compound. Additional details are available on the fostamatinib disodium profile page.
Summary for 217329
| Tradename: | FOSTAMATINIB DISODIUM |
| Applicant: | Annora Pharma |
| Ingredient: | fostamatinib disodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
| Approval Date: | Jun 17, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
| Approval Date: | Jun 17, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
